Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Wolff

Showing results (171-180 of 175) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 175 results.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
JAMA|October 20, 1999
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancerP A Rowlings, S F Williams, K H Antman, et al.
Journal for Immunotherapy of Cancer|February 18, 2026
Antigen-IL-2 CAR-enhancer drives CAR-T fate and stemness, enhancing antitumor efficacy across models independent of IL-2RαHeydar Moravej, Taha Rakhshandehroo, Radia M M Khan, et al.
Journal of Oncology Practice|October 17, 2013
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendationsAndrea M Denicoff, Worta McCaskill-Stevens, Stephen S Grubbs, et al.
Pageof 18

Showing results (171-180 of 175) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 175 results.
Blood|May 23, 1998
A multicenter study of platelet recovery and utilization in patients after myeloablative therapy and hematopoietic stem cell transplantationS H Bernstein, A P Nademanee, J M Vose, et al.
Blood|September 25, 1998
Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantationV Ratanatharathorn, R A Nash, D Przepiorka, et al.
JAMA|October 20, 1999
Factors correlated with progression-free survival after high-dose chemotherapy and hematopoietic stem cell transplantation for metastatic breast cancerP A Rowlings, S F Williams, K H Antman, et al.
Journal for Immunotherapy of Cancer|February 18, 2026
Antigen-IL-2 CAR-enhancer drives CAR-T fate and stemness, enhancing antitumor efficacy across models independent of IL-2RαHeydar Moravej, Taha Rakhshandehroo, Radia M M Khan, et al.
Journal of Oncology Practice|October 17, 2013
The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendationsAndrea M Denicoff, Worta McCaskill-Stevens, Stephen S Grubbs, et al.
Pageof 18